HR 3772
116th Congress
House
Health
Drug therapy
Health care costs and insurance
Health technology, devices, supplies
Home and outpatient care
Medical tests and diagnostic methods
Medicare
Medicare Diagnostic Radiopharmaceutical Payment Equity Act of 2019
Introduced: July 16, 2019
Introduced by:
Peters, Scott H.
Democratic
· California
See on congress.gov
Everywhere this bill has been
3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jul 17, 2019
Referred to the Subcommittee on Health.
Jul 16, 2019
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Jul 16, 2019
Introduced in House
Plain-English summary
Medicare Diagnostic Radiopharmaceutical Payment Equity Act of 2019
This bill establishes separate payment requirements for diagnostic radiopharmaceuticals under the Medicare prospective payment system for hospital outpatient department services. The bill's requirements apply to diagnostic radiopharmaceuticals that have an average daily cost of $500 or more in 2020 and as adjusted based on a specified fee schedule factor in each year thereafter.
What's happening now
Referred to the Subcommittee on Health.
Committees of jurisdiction
3